Thomas McGauley insider trades

Open-market stock purchases and sales by Thomas McGauley, Interim CFO at Tenax Therapeutics, Inc, from SEC Form 4 filings since May 23, 2012.

Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging -47%.

Recent trades

DateStockTradeValue
Jan 30, 2026TENX Tenax Therapeutics, IncBought (not open market)—
Nov 17, 2025TENX Tenax Therapeutics, IncBought$14.7K
Nov 17, 2025TENX Tenax Therapeutics, IncBought$7.3K
Nov 17, 2025TENX Tenax Therapeutics, IncBought$36.1K

Companies traded

  • TENX Tenax Therapeutics, Inc: 3 buys, last Jan 30, 2026
  • GALT Galectin Therapeutics Inc: 1 buy, last Jun 19, 2013

Get free alerts when Thomas McGauley files a new trade →